Cite
Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
MLA
Zhang, Xu-Feng, et al. “Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.” Journal of Gastrointestinal Surgery, vol. 21, no. 11, Nov. 2017, pp. 1821–30. EBSCOhost, https://doi.org/10.1007/s11605-017-3490-2.
APA
Zhang, X.-F., Beal, E., Chakedis, J., Lv, Y., Bagante, F., Aldrighetti, L., Poultsides, G., Bauer, T., Fields, R., Maithel, S., Marques, H., Weiss, M., Pawlik, T., Beal, E. W., Poultsides, G. A., Bauer, T. W., Fields, R. C., Maithel, S. K., Marques, H. P., & Pawlik, T. M. (2017). Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment. Journal of Gastrointestinal Surgery, 21(11), 1821–1830. https://doi.org/10.1007/s11605-017-3490-2
Chicago
Zhang, Xu-Feng, Eliza Beal, Jeffery Chakedis, Yi Lv, Fabio Bagante, Luca Aldrighetti, George Poultsides, et al. 2017. “Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.” Journal of Gastrointestinal Surgery 21 (11): 1821–30. doi:10.1007/s11605-017-3490-2.